NCT00353145 - Gemox as First and Second Line Therapy in Unknown Primary Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2007

Study Completion Date

January 31, 2010

Conditions

Unknown Primary Neoplasms

Interventions

DRUG

Gemcitabine (Gemox)

1000 mg/m\^2, infused at 10 mg/m\^2/min on Day 1 repeated every 14 days (one cycle).

DRUG

Oxaliplatin

100 mg/m\^2 by vein infused on Day 2 over two hours, repeated every 14 days (one cycle).

BEHAVIORAL

Questionnaire

Quality of Life Surveys

Trial Locations (1)

U.T. M.D. Anderson Cancer Center, Houston